The use of Nutraceuticals as Mono- or Adjuvant Therapy to Pharmacotherapies in Major Depressive Disorder
Journal Title: International Neuropsychiatric Disease Journal - Year 2016, Vol 8, Issue 2
Abstract
Objectives: The present review provides an overview of the appropriate literature on the use of nutraceuticals in depression. The goal was to examine whether nutraceuticals, in combination with the current pharmacotherapies or even as mono-therapies, could be effective in depressive patients. Methods: A literature search was conducted on PubMed database for articles using the terms: ‘major depressive disorder’, ‘tricyclic antidepressants’, and ‘SSRIs’ combined with ‘nutraceuticals’, ‘pharmacotherapies’, ‘adjuvant therapies’, ‘amino acids’, ‘biochemical disturbances’, ‘(precursors of) neurotransmitters’, ‘tryptophan’, ‘tyrosine’, ‘phenylalanine’, ‘omega-3 fatty acids’, ‘omega-6 fatty acids’, ‘S-adenosylmethionine’, ‘B-vitamins’, ‘folate’, ‘methyl folate’, or ‘vitamin B12’. Search results were manually reviewed, and relevant reviews and studies were selected for inclusion as suitable. Results: Nutraceuticals may relieve depressive symptoms. In particular tryptophan, omega-3 fatty acids, S-adenosylmethionine, and folate as mono- or adjuvant therapy to current pharmacotherapies in depressive disorder may enhance response and increase efficacy. Discussion: Some nutraceuticals administered as mono- or adjuvant therapy may be useful in the treatment of depressive disorder. Nevertheless, accurate medical diagnoses and consideration of all possible treatments should always be the first step in addressing depressive disorder. Therapy with nutraceuticals should be supervised and doses be adjusted for each patient individually to achieve optimal outcomes.
Authors and Affiliations
Jan Berend Deijen, Lisanne A. E. M. Van Houtum
Keywords
Related Articles
- EP ID EP241821
- DOI 10.9734/INDJ/2016/29568
- Views 176
- Downloads 0
A General Assessment of the Functional Impact of Acute Disseminated Encephalomyelitis
Introduction: Long-term disability in patients with acute disseminated encephalomyelitis (ADEM) is caused not only by neurological deficiency, but also by the difficulties with social and psychological adaptation. Togeth...
Nasal Septum Deviation is Not a Cause of Migraine or Tension Headache
Objective and Aim: Nasal septum deviation (NSD) is an important otorhinolaryngologic cause of headache. We evaluated the frequency of common forms of headache in subjects with NSD. Methods: All participants underwent exa...
Ambient Sulphur Dioxide and Emergency Department Visits for Migraine and Depression
Aims: Depression and migraine are linked especially among women. Little previous research has focused on the potential association between ambient sulphur dioxide (SO2) exposure and emergency department (ED) visits for m...
Cerebrospinal Fluid Biomarkers of Neuroinflammation and Axonal Degeneration in Patients with Multiple Sclerosis
Background: Inflammation mediators have important roles in leukocyte recruitment and the central nervous system (CNS) inflammation and damage. Axonal and neuronal damage are associated with the level of CNS inflammation...
Cholinesterase Inhibitors in Non-age Related Neurodegenerative Dementias
Aims: Dementia is common among the elderly but it can also affect the younger age group. Cholinesterase inhibitors (ChEI) in Alzheimer Dementia (AD) are extensively studied and widely used. This case report aims to illus...